Announcement • 54m
FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 25, 2026 FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 25, 2026. Announcement • May 09
FALCO HOLDINGS Co., Ltd. to Report Fiscal Year 2026 Results on May 12, 2026 FALCO HOLDINGS Co., Ltd. announced that they will report fiscal year 2026 results at 12:00 PM, Tokyo Standard Time on May 12, 2026 Upcoming Dividend • Mar 23
Upcoming dividend of JP¥62.50 per share Eligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Payout ratio is a comfortable 65% but the company is paying out more than the cash it is generating. Trailing yield: 4.8%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.7%). Reported Earnings • Feb 11
Third quarter 2026 earnings released: EPS: JP¥60.68 (vs JP¥54.46 in 3Q 2025) Third quarter 2026 results: EPS: JP¥60.68 (up from JP¥54.46 in 3Q 2025). Revenue: JP¥11.1b (down 1.9% from 3Q 2025). Net income: JP¥606.0m (up 4.8% from 3Q 2025). Profit margin: 5.4% (up from 5.1% in 3Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Announcement • Nov 29
FALCO HOLDINGS Co., Ltd. to Report Q3, 2026 Results on Feb 10, 2026 FALCO HOLDINGS Co., Ltd. announced that they will report Q3, 2026 results on Feb 10, 2026 Reported Earnings • Nov 08
Second quarter 2026 earnings released: EPS: JP¥48.34 (vs JP¥49.86 in 2Q 2025) Second quarter 2026 results: EPS: JP¥48.34 (down from JP¥49.86 in 2Q 2025). Revenue: JP¥10.7b (flat on 2Q 2025). Net income: JP¥482.0m (down 9.4% from 2Q 2025). Profit margin: 4.5% (down from 5.0% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Announcement • Sep 27
FALCO HOLDINGS Co., Ltd. to Report Q2, 2026 Results on Nov 06, 2025 FALCO HOLDINGS Co., Ltd. announced that they will report Q2, 2026 results on Nov 06, 2025 Upcoming Dividend • Sep 22
Upcoming dividend of JP¥62.50 per share Eligible shareholders must have bought the stock before 29 September 2025. Payment date: 02 December 2025. Payout ratio is a comfortable 65% but the company is paying out more than the cash it is generating. Trailing yield: 4.8%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.6%). Reported Earnings • Aug 09
First quarter 2026 earnings released: EPS: JP¥31.64 (vs JP¥24.55 in 1Q 2025) First quarter 2026 results: EPS: JP¥31.64 (up from JP¥24.55 in 1Q 2025). Revenue: JP¥10.9b (up 2.0% from 1Q 2025). Net income: JP¥321.0m (up 23% from 1Q 2025). Profit margin: 2.9% (up from 2.4% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Announcement • Jun 27
FALCO HOLDINGS Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025 FALCO HOLDINGS Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025 Reported Earnings • Jun 27
Full year 2025 earnings released: EPS: JP¥182 (vs JP¥152 in FY 2024) Full year 2025 results: EPS: JP¥182 (up from JP¥152 in FY 2024). Revenue: JP¥43.3b (flat on FY 2024). Net income: JP¥1.92b (up 15% from FY 2024). Profit margin: 4.4% (up from 3.9% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Announcement • Jun 24
FALCO HOLDINGS Co., Ltd. (TSE:4671) announces an Equity Buyback for 250,000 shares, representing 2.46% for ¥565.75 million. FALCO HOLDINGS Co., Ltd. (TSE:4671) announces a share repurchase program. Under the program, the company will repurchase 250,000 shares, representing 2.46% of the outstanding shares, for ¥565.75 million. The shares will be repurchased at ¥2,263 per share. The purpose of the program is to improve capital efficiency and to implement a flexible capital policy that can respond to future changes in the business environment. As of March 31, 2025, the company had 10,155,498 shares outstanding and 724,679 shares in treasury. Reported Earnings • May 15
Full year 2025 earnings released: EPS: JP¥182 (vs JP¥152 in FY 2024) Full year 2025 results: EPS: JP¥182 (up from JP¥152 in FY 2024). Revenue: JP¥43.3b (flat on FY 2024). Net income: JP¥1.92b (up 15% from FY 2024). Profit margin: 4.4% (up from 3.9% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Announcement • May 13
FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 24, 2025 FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 24, 2025. Upcoming Dividend • Mar 21
Upcoming dividend of JP¥63.00 per share Eligible shareholders must have bought the stock before 28 March 2025. Payment date: 24 June 2025. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 4.9%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.7%). Announcement • Mar 01
FALCO HOLDINGS Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025 FALCO HOLDINGS Co., Ltd. announced that they will report fiscal year 2025 results on May 13, 2025 New Risk • Feb 20
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 5.1% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Reported Earnings • Feb 14
Third quarter 2025 earnings released: EPS: JP¥54.46 (vs JP¥59.32 in 3Q 2024) Third quarter 2025 results: EPS: JP¥54.46 (down from JP¥59.32 in 3Q 2024). Revenue: JP¥11.4b (up 3.4% from 3Q 2024). Net income: JP¥578.0m (down 11% from 3Q 2024). Profit margin: 5.1% (down from 5.9% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Announcement • Nov 30
FALCO HOLDINGS Co., Ltd. to Report Q3, 2025 Results on Feb 12, 2025 FALCO HOLDINGS Co., Ltd. announced that they will report Q3, 2025 results on Feb 12, 2025 Announcement • Nov 28
FALCO HOLDINGS Co., Ltd. (TSE:4671) announces an Equity Buyback for 170,000 shares, representing 1.53% for ¥383.01 million. FALCO HOLDINGS Co., Ltd. (TSE:4671) announces a share repurchase program. Under the program, the company will repurchase 170,000 shares, representing 1.53% of the outstanding shares, for ¥383.01 million. The purpose of the program is to improve capital efficiency and to implement a flexible capital policy that can respond to future changes in the business environment. The program is valid till November 29, 2024. As of September 30, 2024, the company had 11,080,177 shares outstanding and 410,041 shares in treasury. Reported Earnings • Nov 10
Second quarter 2025 earnings released: EPS: JP¥49.86 (vs JP¥45.33 in 2Q 2024) Second quarter 2025 results: EPS: JP¥49.86 (up from JP¥45.33 in 2Q 2024). Revenue: JP¥10.6b (flat on 2Q 2024). Net income: JP¥532.0m (up 5.3% from 2Q 2024). Profit margin: 5.0% (up from 4.7% in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Upcoming Dividend • Sep 20
Upcoming dividend of JP¥60.00 per share Eligible shareholders must have bought the stock before 27 September 2024. Payment date: 02 December 2024. Payout ratio is a comfortable 48% and this is well supported by cash flows. Trailing yield: 6.6%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.3%). New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company. Announcement • Aug 27
FALCO HOLDINGS Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024 FALCO HOLDINGS Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024 Reported Earnings • Aug 14
First quarter 2025 earnings released: EPS: JP¥24.55 (vs JP¥11.05 in 1Q 2024) First quarter 2025 results: EPS: JP¥24.55 (up from JP¥11.05 in 1Q 2024). Revenue: JP¥10.7b (flat on 1Q 2024). Net income: JP¥262.0m (up 111% from 1Q 2024). Profit margin: 2.4% (up from 1.2% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Jul 24
Now 21% undervalued Over the last 90 days, the stock has risen 5.3% to JP¥2,365. The fair value is estimated to be JP¥3,004, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 20%. Announcement • Jun 28
FALCO HOLDINGS Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024 FALCO HOLDINGS Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024 Reported Earnings • Jun 26
Full year 2024 earnings: Revenues and EPS in line with analyst expectations Full year 2024 results: EPS: JP¥152 (down from JP¥215 in FY 2023). Revenue: JP¥43.0b (down 8.3% from FY 2023). Net income: JP¥1.67b (down 26% from FY 2023). Profit margin: 3.9% (down from 4.8% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Major Estimate Revision • May 21
Consensus EPS estimates increase by 16%, revenue downgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from JP¥43.5b to JP¥42.8b. EPS estimate rose from JP¥141 to JP¥163. Net income forecast to grow 4.4% next year vs 15% growth forecast for Healthcare industry in Japan. Consensus price target of JP¥2,200 unchanged from last update. Share price was steady at JP¥2,289 over the past week. Announcement • May 15
FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 21, 2024 FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 21, 2024. Reported Earnings • May 12
Full year 2024 earnings: Revenues and EPS in line with analyst expectations Full year 2024 results: EPS: JP¥152 (down from JP¥215 in FY 2023). Revenue: JP¥43.0b (down 8.3% from FY 2023). Net income: JP¥1.67b (down 26% from FY 2023). Profit margin: 3.9% (down from 4.8% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 1.0% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Major Estimate Revision • Apr 25
Consensus EPS estimates increase by 27% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from JP¥42.0b to JP¥43.0b. EPS estimate increased from JP¥121 to JP¥153 per share. Net income forecast to shrink 22% next year vs 16% growth forecast for Healthcare industry in Japan . Consensus price target up from JP¥1,800 to JP¥2,200. Share price was steady at JP¥2,245 over the past week. Upcoming Dividend • Mar 21
Upcoming dividend of JP¥75.00 per share Eligible shareholders must have bought the stock before 28 March 2024. Payment date: 26 June 2024. Payout ratio is a comfortable 40% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Within top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.2%). Announcement • Mar 02
FALCO HOLDINGS Co., Ltd. to Report Fiscal Year 2024 Results on May 10, 2024 FALCO HOLDINGS Co., Ltd. announced that they will report fiscal year 2024 results on May 10, 2024 New Risk • Feb 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 5.4% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (150% cash payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Reported Earnings • Feb 10
Third quarter 2024 earnings released: EPS: JP¥59.32 (vs JP¥39.46 in 3Q 2023) Third quarter 2024 results: EPS: JP¥59.32 (up from JP¥39.46 in 3Q 2023). Revenue: JP¥11.0b (down 6.3% from 3Q 2023). Net income: JP¥646.0m (up 56% from 3Q 2023). Profit margin: 5.9% (up from 3.5% in 3Q 2023). Revenue is forecast to stay flat during the next 3 years compared to a 5.3% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Announcement • Dec 28
FALCO HOLDINGS Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024 FALCO HOLDINGS Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024 Reported Earnings • Nov 09
Second quarter 2024 earnings released: EPS: JP¥45.33 (vs JP¥65.15 in 2Q 2023) Second quarter 2024 results: EPS: JP¥45.33 (down from JP¥65.15 in 2Q 2023). Revenue: JP¥10.7b (down 15% from 2Q 2023). Net income: JP¥505.0m (down 26% from 2Q 2023). Profit margin: 4.7% (down from 5.4% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 5.6% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 7% per year. New Risk • Oct 11
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 6.2% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 6.2% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (100% cash payout ratio). Profit margins are more than 30% lower than last year (4.2% net profit margin). Shareholders have been diluted in the past year (5.2% increase in shares outstanding). Upcoming Dividend • Sep 21
Upcoming dividend of JP¥40.00 per share at 3.3% yield Eligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. Payout ratio is a comfortable 35% but the company is paying out more than the cash it is generating. Trailing yield: 3.3%. Within top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (2.1%). Announcement • Aug 27
FALCO HOLDINGS Co., Ltd. to Report Q2, 2024 Results on Nov 08, 2023 FALCO HOLDINGS Co., Ltd. announced that they will report Q2, 2024 results on Nov 08, 2023 Reported Earnings • Aug 12
First quarter 2024 earnings released: EPS: JP¥11.05 (vs JP¥42.24 in 1Q 2023) First quarter 2024 results: EPS: JP¥11.05 (down from JP¥42.24 in 1Q 2023). Revenue: JP¥10.6b (down 8.0% from 1Q 2023). Net income: JP¥124.0m (down 72% from 1Q 2023). Profit margin: 1.2% (down from 3.8% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 5.8% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Announcement • Aug 11
FALCO HOLDINGS Co., Ltd. (TSE:4671) announces an Equity Buyback for 600,000 shares, representing 5.33% for ¥1,200 million. FALCO HOLDINGS Co., Ltd. (TSE:4671) announces a share repurchase program. Under the program, the company will repurchase 600,000 shares, representing 5.33% of the outstanding shares, for ¥1,200 million. The purpose of the program is increase shareholder returns, improve capital efficiency, and address changes in the business environment going forward. The program is valid till March 22, 2024. As of March 31, 2023, the company had 11,252,236 shares outstanding and 57,941 shares in treasury. Buying Opportunity • Jul 25
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 6.7%. The fair value is estimated to be JP¥2,335, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 29%. For the next 3 years, revenue is forecast to decline by 0.8% per annum. Earnings is also forecast to decline by 5.6% per annum over the same time period. Buying Opportunity • Jul 06
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 3.7%. The fair value is estimated to be JP¥2,335, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 29%. For the next 3 years, revenue is forecast to decline by 0.8% per annum. Earnings is also forecast to decline by 5.6% per annum over the same time period. Announcement • Jun 30
FALCO HOLDINGS Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023 FALCO HOLDINGS Co., Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023 Reported Earnings • May 18
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: JP¥215 (down from JP¥339 in FY 2022). Revenue: JP¥46.9b (down 6.2% from FY 2022). Net income: JP¥2.26b (down 36% from FY 2022). Profit margin: 4.8% (down from 7.1% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 7.4%. Revenue is forecast to stay flat during the next 3 years compared to a 7.0% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Announcement • May 14
FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 23, 2023 FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 23, 2023. Buying Opportunity • May 10
Now 20% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be JP¥2,533, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.6% over the last 3 years. Earnings per share has grown by 38%. For the next 3 years, revenue is forecast to decline by 2.0% per annum. Earnings is also forecast to decline by 9.8% per annum over the same time period. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥68.00 per share at 3.3% yield Eligible shareholders must have bought the stock before 30 March 2023. Payment date: 23 June 2023. Payout ratio is a comfortable 25% and this is well supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%). Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: JP¥39.46 (vs JP¥38.13 in 3Q 2022) Third quarter 2023 results: EPS: JP¥39.46 (up from JP¥38.13 in 3Q 2022). Revenue: JP¥11.7b (flat on 3Q 2022). Net income: JP¥415.0m (up 4.3% from 3Q 2022). Profit margin: 3.5% (up from 3.4% in 3Q 2022). Revenue is expected to decline by 3.8% p.a. on average during the next 3 years, while revenues in the Healthcare industry in Japan are expected to grow by 5.9%. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Announcement • Nov 27
FALCO HOLDINGS Co., Ltd. to Report Q3, 2023 Results on Feb 08, 2023 FALCO HOLDINGS Co., Ltd. announced that they will report Q3, 2023 results on Feb 08, 2023 Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 2 independent directors (7 non-independent directors). Audit & Supervisory Committee Member Hiroshi Eguchi was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Nov 10
Second quarter 2023 earnings released: EPS: JP¥65.15 (vs JP¥123 in 2Q 2022) Second quarter 2023 results: EPS: JP¥65.15 (down from JP¥123 in 2Q 2022). Revenue: JP¥12.6b (flat on 2Q 2022). Net income: JP¥683.0m (down 47% from 2Q 2022). Profit margin: 5.4% (down from 10% in 2Q 2022). Revenue is expected to decline by 3.5% p.a. on average during the next 3 years, while revenues in the Healthcare industry in Japan are expected to grow by 5.2%. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Announcement • Sep 28
FALCO HOLDINGS Co., Ltd. to Report Q2, 2023 Results on Nov 08, 2022 FALCO HOLDINGS Co., Ltd. announced that they will report Q2, 2023 results on Nov 08, 2022 Upcoming Dividend • Sep 22
Upcoming dividend of JP¥32.00 per share Eligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.2%). Reported Earnings • Aug 07
First quarter 2023 earnings released: EPS: JP¥42.24 (vs JP¥81.39 in 1Q 2022) First quarter 2023 results: EPS: JP¥42.24 (down from JP¥81.39 in 1Q 2022). Revenue: JP¥11.6b (down 3.8% from 1Q 2022). Net income: JP¥442.0m (down 48% from 1Q 2022). Profit margin: 3.8% (down from 7.0% in 1Q 2022). Over the next year, revenue is expected to shrink by 9.4% compared to a 4.6% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Announcement • Jun 29
FALCO HOLDINGS Co., Ltd. to Report Q1, 2023 Results on Aug 05, 2022 FALCO HOLDINGS Co., Ltd. announced that they will report Q1, 2023 results on Aug 05, 2022 Reported Earnings • Jun 26
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: JP¥339 (up from JP¥179 in FY 2021). Revenue: JP¥50.0b (up 15% from FY 2021). Net income: JP¥3.53b (up 91% from FY 2021). Profit margin: 7.1% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) also surpassed analyst estimates by 18%. Over the next year, revenue is expected to shrink by 10% compared to a 3.8% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • May 31
Consensus EPS estimates increase by 24% The consensus outlook for earnings per share (EPS) in 2023 has improved. 2023 revenue forecast increased from JP¥44.0b to JP¥45.0b. EPS estimate increased from JP¥144 to JP¥178 per share. Net income forecast to shrink 47% next year vs 5.7% growth forecast for Healthcare industry in Japan . Consensus price target of JP¥2,400 unchanged from last update. Share price was steady at JP¥2,175 over the past week. Announcement • May 18
FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 22, 2022 FALCO HOLDINGS Co., Ltd., Annual General Meeting, Jun 22, 2022. Reported Earnings • May 16
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: JP¥339 (up from JP¥179 in FY 2021). Revenue: JP¥50.0b (up 15% from FY 2021). Net income: JP¥3.53b (up 91% from FY 2021). Profit margin: 7.1% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) also surpassed analyst estimates by 18%. Over the next year, revenue is expected to shrink by 12% compared to a 5.0% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Price Target Changed • Apr 27
Price target decreased to JP¥2,400 Down from JP¥2,700, the current price target is provided by 1 analyst. New target price is 16% above last closing price of JP¥2,071. Stock is up 24% over the past year. The company is forecast to post earnings per share of JP¥287 for next year compared to JP¥179 last year. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 2 independent directors (7 non-independent directors). Audit & Supervisory Committee Member Hiroshi Eguchi was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Apr 08
FALCO HOLDINGS Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022 FALCO HOLDINGS Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022 Upcoming Dividend • Mar 23
Upcoming dividend of JP¥36.00 per share Eligible shareholders must have bought the stock before 30 March 2022. Payment date: 23 June 2022. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (2.0%). Reported Earnings • Feb 09
Third quarter 2022 earnings: EPS exceeds analyst expectations Third quarter 2022 results: EPS: JP¥38.13 (down from JP¥56.80 in 3Q 2021). Revenue: JP¥11.7b (up 1.6% from 3Q 2021). Net income: JP¥398.0m (down 32% from 3Q 2021). Profit margin: 3.4% (down from 5.1% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 16%. Over the next year, revenue is expected to shrink by 6.6% compared to a 5.0% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 10
Second quarter 2022 earnings released: EPS JP¥123 (vs JP¥56.78 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥12.7b (up 19% from 2Q 2021). Net income: JP¥1.28b (up 118% from 2Q 2021). Profit margin: 10% (up from 5.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Sep 22
Upcoming dividend of JP¥28.00 per share Eligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 3.1%. Within top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.8%). Reported Earnings • Aug 06
First quarter 2022 earnings released: EPS JP¥81.39 (vs JP¥23.92 loss in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥12.0b (up 23% from 1Q 2021). Net income: JP¥845.0m (up JP¥1.10b from 1Q 2021). Profit margin: 7.0% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Reported Earnings • Jun 26
Full year 2021 earnings released: EPS JP¥179 (vs JP¥117 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥43.6b (up 1.0% from FY 2020). Net income: JP¥1.85b (up 49% from FY 2020). Profit margin: 4.2% (up from 2.9% in FY 2020). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 5% per year. Reported Earnings • May 14
Full year 2021 earnings released: EPS JP¥179 (vs JP¥117 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥43.6b (up 1.0% from FY 2020). Net income: JP¥1.85b (up 49% from FY 2020). Profit margin: 4.2% (up from 2.9% in FY 2020). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 2% per year. Major Estimate Revision • Mar 26
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 EPS estimate increased from JP¥125 to JP¥154. Revenue forecast steady at JP¥42.9b. Net income forecast to grow 116% next year vs 14% growth forecast for Healthcare industry in Japan. Consensus price target of JP¥2,000 unchanged from last update. Share price rose 5.4% to JP¥1,807 over the past week. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥26.00 per share Eligible shareholders must have bought the stock before 30 March 2021. Payment date: 24 June 2021. Trailing yield: 3.0%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.5%). Announcement • Mar 05
Molecular Health GmbH and FALCO HOLDINGS Co., Ltd. Team Up to Provide Genetic Analysis Services Using MH Guide/BRCA and MH Guide/Mendel Molecular Health GmbH announced that it has entered into an agreement with FALCO biosystems Ltd. under which FALCO biosystems will use the products MH Guide/BRCA and MH Guide/Mendel to evaluate inherited genetic variants of BRCA1/2 and other heritable cancer-associated genes. Inherited genetic variants can predispose an individual to cancer. Hereditary Breast and Ovarian Cancer (HBOC) Syndrome, for example, is caused by pathogenic mutations in distinct genes such as BRCA1/2, MLH1, MSH6, PMS2, respectively. Therefore, testing BRCA1/2 genes and other heritable cancer-associated genes is becoming increasingly important: both to evaluate the affected patient's individual risk of developing cancer[1],[2], and as a predictive biomarker and companion diagnostic test for certain drugs[3]. Whereas MH Guide/BRCA detects variants in HBOC-associated genes, MH Guide/Mendel can analyze large gene panels as well as whole-exome or whole-genome data, so that many different hereditary diseases can be identified at once. Under the terms of this collaboration, FALCO biosystems will perform the next-generation sequencing (NGS) process and variant identification using blood samples provided by the patient. Molecular Health will then analyze the variant data using MH Guide/BRCA or MH Guide/Mendel. To accurately distinguish benign from pathogenic variants, MH uses an in-house proprietary database called MH Dataome, which integrates the Japanese reference genome ToMMo 3.5KJPNv2 (MAF >= 1%) for improved variant filtering and classification. Molecular Health gratefully acknowledges the contribution of Tohoku Medical Megabank. Is New 90 Day High Low • Feb 26
New 90-day low: JP¥1,550 The company is down 3.0% from its price of JP¥1,602 on 27 November 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare industry, which is up 4.0% over the same period. Major Estimate Revision • Jan 29
Analysts increase EPS estimates to JP¥126 The 2021 consensus revenue estimate increased from JP¥41.2b to JP¥42.5b. The earnings per share estimate also received an upgrade from JP¥96.70 to JP¥126 for the same period. Net income is expected to grow by 7.3% next year compared to 13% growth forecast for the Healthcare industry in Japan. The consensus price target increased from JP¥1,800 to JP¥2,000. Share price is up 3.2% to JP¥1,704 over the past week. Is New 90 Day High Low • Jan 27
New 90-day high: JP¥1,790 The company is up 18% from its price of JP¥1,521 on 29 October 2020. The Japanese market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare industry, which is up 12% over the same period. Announcement • Jan 12
FALCO HOLDINGS Co., Ltd. to Report Q3, 2021 Results on Feb 09, 2021 FALCO HOLDINGS Co., Ltd. announced that they will report Q3, 2021 results on Feb 09, 2021 Is New 90 Day High Low • Jan 12
New 90-day high: JP¥1,690 The company is up 15% from its price of JP¥1,472 on 14 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare industry, which is up 4.0% over the same period. Price Target Changed • Dec 01
Price target lowered to JP¥1,800 Down from JP¥2,400, the current price target is provided by 1 analyst. The new target price is 11% above the current share price of JP¥1,616. As of last close, the stock is down 7.2% over the past year. Announcement • Oct 08
FALCO HOLDINGS Co., Ltd. to Report Q2, 2021 Results on Nov 05, 2020 FALCO HOLDINGS Co., Ltd. announced that they will report Q2, 2021 results on Nov 05, 2020 Announcement • Jun 28
FALCO HOLDINGS Co., Ltd. to Report Q1, 2021 Results on Aug 06, 2020 FALCO HOLDINGS Co., Ltd. announced that they will report Q1, 2021 results on Aug 06, 2020